SMAD5 and esophageal squamous cell carcinoma: Otherwise, miR-145 is effective in ESCC growth, proliferation, and invasion by directly targeting SMAD5 and it is considered a biomarker of late-stage ESCC, poor prognosis, unfavorable therapeutic outcomes, and a potential target for both diagnostic tools and therapeutic strategies [42].